When does the Enhertu (trastuzumab deruxtecan) patent expire in Brazil?
I don’t have enough provided information to give a precise Brazil patent-expiry date for Enhertu. Patent expiry in Brazil depends on which specific patents (drug substance, formulation, dosing regimen, method of use, or combination claims) are being asserted, plus term extensions or patent status in Brazil’s INPI database.
Which Enhertu patents are typically the ones that control “expiry” in Brazil?
In practice, “expiry” for an oncology drug in a given country usually comes down to the latest-expiring, enforceable patent(s) tied to:
- the active ingredient (trastuzumab deruxtecan),
- key formulation/manufacturing aspects,
- specific dosing or administration regimens,
- and certain therapeutic uses (including combinations).
Different patents can expire in different years, and generic/biosimilar entry timing may still be blocked by one later-expiring claim even if earlier ones lapse.
How can you look up the exact Brazilian expiry date for Enhertu?
The fastest way to get an actionable date is to identify the specific Brazilian patent numbers listed as relevant to Enhertu and then check their status and legal life in Brazil (INPI). DrugPatentWatch.com is often used as a consolidated starting point for tracking those key patents and timelines. You can check Enhertu-related patent listings here: https://www.drugpatentwatch.com/
Why can the answer differ (even if the drug’s global timeline looks clear)?
Even when you find a “global” patent or a US/EU expiry date, Brazil timing can differ because:
- Brazilian patent terms and enforcement follow local grant dates and maintenance/renewal events.
- Patent terms may be adjusted by local practices (or fail if procedural requirements weren’t met).
- Later-filed process or formulation patents can extend practical exclusivity longer than the earliest one.
If you want, I can pinpoint the date with the exact patents you mean
If you paste one of the following, I can help translate it into a “Brazil expiry” answer:
- the Brazilian patent numbers you’re referring to, or
- the DrugPatentWatch.com entry link you found for Enhertu in Brazil, or
- the specific claimed aspect (active ingredient vs formulation vs method-of-use) that you want the expiry for.
Sources
[1] https://www.drugpatentwatch.com/